American Healthcare REIT, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by American Healthcare REIT, Inc. (NYSE: AHR) on November 26, 2025, covering events occurring on November 24, 2025. The filing details the closure of a public offering of common stock and the subsequent exercise of an underwriter's option to purchase additional shares.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial activity reported is the capital raise through the sale of equity:
- Initial Offering: 8,100,000 shares of Common Stock closed on November 24, 2025.
- Option Exercise: The underwriter exercised its option in full to purchase an additional 1,215,000 shares.
- Total Shares Issued: 9,315,000 shares (8,100,000 initial + 1,215,000 additional).
- Proceeds Usage: Net proceeds are intended for general corporate purposes, including potential future investments, via contribution to the Operating Partnership.
Material Changes
The material change reported is the increase in outstanding common stock and the execution of an Additional Forward Sale Agreement. Under this agreement, the Forward Seller borrowed and sold 1,215,000 shares on November 26, 2025, to hedge the Forward Purchaser's obligations. The Company intends to deliver these shares upon physical settlement no later than May 20, 2027, in exchange for cash proceeds equal to the public offering price less underwriting discounts.
Guidance, Outlook, and Risks
Management commentary indicates the proceeds will be used for general corporate purposes and potential future investments. The filing notes that settlement of the Additional Forward Sale Agreement is subject to the Company's right to elect cash or net share settlement under certain conditions. No specific financial guidance or new risk factors were disclosed in this specific report beyond the standard terms of the forward sale agreement.
Investor Verification Checklist
- Verify the exact public offering price per share to calculate total gross proceeds.
- Confirm the specific underwriting discounts and commissions to determine net proceeds.
- Review the full text of the Additional Forward Sale Agreement (Exhibit 1.1) for settlement conditions and adjustment mechanisms.
- Check subsequent filings for the actual settlement date and method (cash vs. net share) between November 2025 and May 2027.